JPWO2020142701A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020142701A5 JPWO2020142701A5 JP2021539410A JP2021539410A JPWO2020142701A5 JP WO2020142701 A5 JPWO2020142701 A5 JP WO2020142701A5 JP 2021539410 A JP2021539410 A JP 2021539410A JP 2021539410 A JP2021539410 A JP 2021539410A JP WO2020142701 A5 JPWO2020142701 A5 JP WO2020142701A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- international
- xiaflex
- publication
- application publication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024169863A JP2025016453A (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788916P | 2019-01-06 | 2019-01-06 | |
| US62/788,916 | 2019-01-06 | ||
| PCT/US2020/012202 WO2020142701A1 (en) | 2019-01-06 | 2020-01-03 | Collagenase formulations and methods of producing the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024169863A Division JP2025016453A (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022516569A JP2022516569A (ja) | 2022-02-28 |
| JPWO2020142701A5 true JPWO2020142701A5 (https=) | 2022-12-19 |
| JP2022516569A5 JP2022516569A5 (https=) | 2022-12-19 |
| JP7565280B2 JP7565280B2 (ja) | 2024-10-10 |
Family
ID=69845512
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539410A Active JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
| JP2024169863A Pending JP2025016453A (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024169863A Pending JP2025016453A (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20220305094A1 (https=) |
| EP (1) | EP3906014A1 (https=) |
| JP (2) | JP7565280B2 (https=) |
| KR (1) | KR20210113271A (https=) |
| CN (1) | CN113382714A (https=) |
| AU (2) | AU2020204922B2 (https=) |
| BR (1) | BR112021012675A2 (https=) |
| IL (2) | IL321891A (https=) |
| MX (1) | MX2021008017A (https=) |
| WO (1) | WO2020142701A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113025599B (zh) * | 2021-04-02 | 2023-09-12 | 重庆科润生物医药研发有限公司 | 一种重组溶组织梭菌i型胶原酶及其制备方法和应用 |
| CN112941058B (zh) * | 2021-04-02 | 2023-12-05 | 重庆科润生物医药研发有限公司 | 一种重组溶组织梭菌ii型胶原酶及其制备方法和应用 |
| CN114264633B (zh) * | 2022-02-10 | 2022-09-06 | 上海蓝长科技集团有限公司 | 一种福尔马肼聚合物冻干粉及制备方法 |
| AU2023232693A1 (en) * | 2022-03-08 | 2024-09-19 | Connext Co.,Ltd. | Composition comprising collagenase, calcium, histidine, and glycine, and method for stabilizing collagenase |
| CN119656117B (zh) * | 2024-12-18 | 2025-08-29 | 远大生命科学(鞍山)有限公司 | 一种药物组合物及其制备方法和用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2921180B1 (en) * | 1999-02-22 | 2019-08-14 | University of Connecticut | Albumin-free factor VIII formulations |
| US6440414B1 (en) * | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
| US20070224184A1 (en) * | 2006-02-22 | 2007-09-27 | The Research Foundation Of The State University Of New York | Method for treating cellulite |
| CN101312744A (zh) | 2005-11-22 | 2008-11-26 | 惠氏公司 | 免疫球蛋白融合蛋白制剂 |
| US7811560B2 (en) | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
| ES2388219T3 (es) * | 2008-06-02 | 2012-10-10 | F. Hoffmann-La Roche Ag | Purificación mejorada de colagenasas a partir de un cultivo líquido de Clostridium histolyticum |
| WO2012125948A1 (en) | 2011-03-16 | 2012-09-20 | Biospecifics Technologies Corp. | Compositions and methods for producing clostridial collagenases |
| JP2014530873A (ja) * | 2011-10-21 | 2014-11-20 | オーキシリウム インターナショナル ホールディングス，インコーポレイテッド | Ｅｆｐの治療または低減方法 |
| PT2802652T (pt) | 2012-01-12 | 2019-09-10 | Endo Global Ventures | Enzimas de clostridium histolyticum |
| EP3834840B8 (en) | 2013-03-15 | 2025-09-17 | Endo Biologics Limited | Treatment method and product for uterine fibroids using purified collagenase |
| US10137179B2 (en) * | 2016-05-18 | 2018-11-27 | Hyalo Technologies, LLC | Composition and method of preparation of protease microparticulate slow release preparation |
| CA3039655A1 (en) * | 2016-10-07 | 2018-04-12 | Regeneron Pharmaceuticals, Inc. | Room temperature stable lyophilized protein |
| EP4591945A3 (en) * | 2017-03-01 | 2026-04-15 | Endo Operations Limited | Apparatus and method for assessing and treating cellulite |
-
2020
- 2020-01-03 US US17/419,899 patent/US20220305094A1/en not_active Abandoned
- 2020-01-03 AU AU2020204922A patent/AU2020204922B2/en active Active
- 2020-01-03 WO PCT/US2020/012202 patent/WO2020142701A1/en not_active Ceased
- 2020-01-03 IL IL321891A patent/IL321891A/en unknown
- 2020-01-03 BR BR112021012675-9A patent/BR112021012675A2/pt active Search and Examination
- 2020-01-03 MX MX2021008017A patent/MX2021008017A/es unknown
- 2020-01-03 KR KR1020217024557A patent/KR20210113271A/ko not_active Ceased
- 2020-01-03 CN CN202080010875.3A patent/CN113382714A/zh active Pending
- 2020-01-03 JP JP2021539410A patent/JP7565280B2/ja active Active
- 2020-01-03 IL IL284270A patent/IL284270B2/en unknown
- 2020-01-03 EP EP20712071.8A patent/EP3906014A1/en active Pending
-
2023
- 2023-09-29 US US18/478,368 patent/US12303557B2/en active Active
-
2024
- 2024-09-30 JP JP2024169863A patent/JP2025016453A/ja active Pending
-
2025
- 2025-04-22 US US19/185,838 patent/US20250249080A1/en active Pending
- 2025-06-30 AU AU2025204915A patent/AU2025204915A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schultz et al. | Bullous diseases in children: a review of clinical features and treatment options | |
| JP2011088927A5 (https=) | ||
| Parker et al. | The effects of oral ibopamine in patients with mild heart failure—a double blind placebo controlled comparison to furosemide | |
| EA200000702A1 (ru) | Пролекарства ингибиторов аспартилпротеаз | |
| CN1324234A (zh) | 果糖胺氧化酶,拮抗剂和抑制剂 | |
| RU2007102698A (ru) | Композиции и способы лечения неврологических нарушений | |
| Maclean et al. | Stabilization of proteins by low molecular weight multi‐ions | |
| FR2608045A1 (fr) | Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome | |
| JP2018505890A5 (https=) | ||
| JPWO2020142701A5 (https=) | ||
| JP2019023202A (ja) | Ｌｓｄ１阻害剤を用いて多発性硬化症を処置する方法 | |
| Satturwar et al. | Formulation and evaluation of ketoconazole niosomes | |
| CA2476825A1 (en) | Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases | |
| Frulloni et al. | Salivary gland involvement in patients with chronic pancreatitis | |
| Henry et al. | A randomized prospective trial of OKT3 induction in the current immunosuppression era | |
| Soniwala et al. | Various approaches in dissolution enhancement of Rofecoxib | |
| TW201328692A (zh) | 脫髓鞘疾病之治療劑及預防劑 | |
| CA2166017A1 (en) | Pharmaceutical composition for the dermatitis | |
| EP2624829B1 (en) | Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria | |
| JPWO2022120391A5 (https=) | ||
| Möller | Clinical response to gold as a circulating contact allergen | |
| World Health Organization | Vaccine Research and Development: Rotavirus vaccines for developing countries= Recherche et développement en matière de vaccins: Vaccins antirotavirus pour les pays en développement | |
| JP2012171909A (ja) | 糖化阻害剤 | |
| Alahmadi et al. | Detrimental Effects of Elevated Temperatures on the Structure and Activity of Phenylalanine Ammonia Lyase-Bovine Serum Albumin Mixtures and the Stabilizing Potential of Surfactant and Sugars | |
| VOGT et al. | Safety and tolerability of prolonged-release nicotinic acid in patients aged> 65 years enrolled in NAUTILUS |